The Current Ratio as of December 2025 (TTM) for Australian Clinical Labs Limited (ACL.AX) is 0.55

According to Australian Clinical Labs Limited’s latest financial reports and current stock price. The company's current Current Ratio is 0.55. This represents a change of -9.34% compared to the average of 0.61 of the last 4 quarters.

Australian Clinical Labs Limited (ACL.AX) Historical Current Ratio (quarterly & annually)

How has ACL.AX Current Ratio performed in the past?

The mean historical Current Ratio of Australian Clinical Labs Limited over the last ten years is 0.79. The current 0.55 Current Ratio has changed 6.93% with respect to the historical average. Over the past ten years (40 quarters), ACL.AX's Current Ratio was at its highest in in the June 2017 quarter at 1.08. The Current Ratio was at its lowest in in the December 2016 quarter at 0.

Australian Clinical Labs Limited (ACL.AX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Australian Clinical Labs Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Australian Clinical Labs Limited (ACL.AX) Average Current Ratio

How has ACL.AX Current Ratio performed in the past?

The current Current Ratio of Australian Clinical Labs Limited (ACL.AX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Australian Clinical Labs Limited (ACL.AX) Current Ratio vs. Peers

How is ACL.AX’s Current Ratio compared to its peers?

Australian Clinical Labs Limited’s Current Ratio is greater than Oceania Healthcare Limited (0.11), less than Healius Limited (0.56), less than Paragon Care Limited (1.17), less than Clinuvel Pharmaceuticals Limited (9.66), less than EBR Systems, Inc. (7.94), less than Cogstate Limited (3.77), less than Monash IVF Group Limited (0.68), less than Race Oncology Limited (10.29), less than Immutep Limited (11.69), less than Mayne Pharma Group Limited (1.35),

Build a custom stock screener for Australian Clinical Labs Limited (ACL.AX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Australian Clinical Labs Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Australian Clinical Labs Limited (ACL.AX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Australian Clinical Labs Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.